Contact
Please use this form to send email to PR contact of this press release:
SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases
TO:
Please use this form to send email to PR contact of this press release:
SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases
TO: